Litcius/Paper detail

Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial

Takehito Shukuya, Tetsuhiko Asao, Yasushi Goto, Tomoyasu Mimori, Koichi Takayama, Kyoichi Kaira, Hiroshi Tanaka, Ryo Ko, Yoshihiro Amano, Motoko Tachihara, Takuji Suzuki, Junko Tanizaki, Shunichi Sugawara, Yoshitaka Zenke, Yukina Shirai, Takuo Hayashi, Keita Mori, Kazuhisa Takahashi

2025The Lancet Oncology17 citationsDOI

Topics & Concepts

AtezolizumabCarboplatinMedicinePaclitaxelThymic carcinomaOncologyInternal medicineCarcinomaChemotherapyCisplatinCancerImmunotherapyNivolumabMyasthenia Gravis and ThymomaAllergic Rhinitis and SensitizationAdrenal Hormones and Disorders